Drug targeting with nanoparticles.
Nanoparticles are colloidal polymeric particles (size < 1000 nm) to which drugs are bound by sorption, incorporation, or chemical binding. After intravenous injection they normally distribute into the organs of the reticuloendothelial system (liver, spleen, lungs, bone marrow). However, their body distribution can be altered by coating with surfactants or with physiological components such as serum complement factors. The influence of these coatings on the body distribution and possible mechanisms for the alteration of this distribution are discussed. Differently coated nanoparticles can be used for the targeting of bound drugs to tumors, to the brain, and to inflamed areas in the body.
18 references, click to expand
-
The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338).FEBS Lett. 1984 Feb 13;167(1):79-82 PMID: 6698206
-
Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting.Pharm Res. 1992 Apr;9(4):541-6 PMID: 1495900
-
Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles).Graefes Arch Clin Exp Ophthalmol. 1989;227(2):188-93 PMID: 2721988
-
Distribution of polyhexyl cyanoacrylate nanoparticles in nude mice bearing human osteosarcoma.J Pharm Sci. 1986 Mar;75(3):256-8 PMID: 3457949
-
Body distribution of 75Se-radiolabeled silica nanoparticles covalently coated with omega-functionalized surfactants after intravenous injection in rats.J Drug Target. 1994;2(1):61-77 PMID: 8069585
-
Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles.Invest New Drugs. 1992 Aug;10(3):191-9 PMID: 1428729
-
Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats.Pharm Res. 1992 Dec;9(12):1534-9 PMID: 1488394
-
Comparative study on the cytostatic effects and the tissue distribution of 5-fluorouracil in a free form and bound to polybutylcyanoacrylate nanoparticles in sarcoma 180-bearing mice.Oncology. 1983;40(5):363-6 PMID: 6684746
-
Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models.J Microencapsul. 1993 Jan-Mar;10(1):101-14 PMID: 8445503
-
Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles.J Microencapsul. 1992 Jan-Mar;9(1):19-28 PMID: 1613640
-
Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles.J Pharm Sci. 1982 Jul;71(7):790-2 PMID: 7120064
-
The transport of microspheres from the gastro-intestinal tract to inflammatory air pouches in the rat.J Pharm Pharmacol. 1989 Mar;41(3):194-6 PMID: 2568449
-
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties.J Pharm Pharmacol. 1979 May;31(5):331-2 PMID: 37304
-
The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.Life Sci. 1987 Jan 26;40(4):367-74 PMID: 3807638
-
Interaction of serum components with poly(methylmethacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats.J Drug Target. 1993;1(1):15-9 PMID: 8069540
-
Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis.Electrophoresis. 1993 Dec;14 (12 ):1382-7 PMID: 8137807
-
Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor.Eur J Cancer. 1980 Nov;16(11):1441-5 PMID: 7227421
-
Evaluation of nanoparticles as drug-delivery systems. II: Comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter greater than 1 micron), liposomes, and emulsions.Pharm Acta Helv. 1983;58(8):217-26 PMID: 6622500
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
